FDANonrulemakingFDA-2025-N-2489

Who commented on this docket

Onshoring Manufacturing of Drugs and Biological Products; Public Meeting; Request for Comments

18 organizations filed 18 public comments on Onshoring Manufacturing of Drugs and Biological Products; Public Meeting; Request for Comments, at the Food and Drug Administration. The comment window closed 271d ago.

Organizations
18
Comments
18
RIN
Comment window
closed 271d ago

Commenters (18)

  • Alliance for Regenerative Medicinetrade assoc.
    1 filing · confidence 85%
  • American Society of Gene & Cell Therapytrade assoc.
    1 filing · confidence 85%
  • AuriosX Inc.unverified attribution
    1 filing · confidence 70%
  • BioProcess Resources LLCunverified attribution
    1 filing · confidence 70%
  • Council on Strategic Riskstrade assoc.
    1 filing · confidence 85%
  • Eli Lilly and Companyunverified attribution
    1 filing · confidence 70%
  • Massachusetts Biotechnology Associationtrade assoc.
    1 filing · confidence 85%
  • North Carolina Inc.unverified attribution
    1 filing · confidence 70%
  • Pharma & Biopharma Outsourcing Associationtrade assoc.
    1 filing · confidence 85%
  • Plano Pharmaceuticals Inc.unverified attribution
    1 filing · confidence 70%
  • Plasma Protein Therapeutics Associationtrade assoc.
    1 filing · confidence 85%
  • Premier Inc.unverified attribution
    1 filing · confidence 70%
  • Sentio BioSciences LLCunverified attribution
    1 filing · confidence 70%
  • The Ritedose Corporationunverified attribution
    1 filing · confidence 70%
  • Ultragenyx Pharmaceutical Inc.unverified attribution
    1 filing · confidence 70%
View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.